Evidence map›Paper›PMID 32511433›Full record

ArticlemedRxiv : the preprint server for health sciences2020

Comparative dynamic aerosol efficiencies of three emergent coronaviruses and the unusual persistence of SARS-CoV-2 in aerosol suspensions.

A C Fears, W B Klimstra, P Duprex, A Hartman, S C Weaver, K C Plante, D Mirchandani, J A Plante, P V Aguilar, D Fernández and 10 more

Abstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

A C FearsTulane School of Medicine, Tulane National Primate Research Center, New Orleans, LA.
W B KlimstraCenter for Vaccine Research, University of Pittsburgh, Pittsburgh, PA.
P DuprexCenter for Vaccine Research, University of Pittsburgh, Pittsburgh, PA.
A HartmanTulane School of Medicine, Tulane National Primate Research Center, New Orleans, LA.
S C WeaverWorld Reference Center for Emerging Viruses and Arboviruses, Institute for Human Infections and Immunity, and Department of Pathology and Center for Tropical Diseases, University of Texas Medical Branch, Galveston, TX.
K C PlanteWorld Reference Center for Emerging Viruses and Arboviruses, Institute for Human Infections and Immunity, and Department of Pathology and Center for Tropical Diseases, University of Texas Medical Branch, Galveston, TX.
D MirchandaniWorld Reference Center for Emerging Viruses and Arboviruses, Institute for Human Infections and Immunity, and Department of Pathology and Center for Tropical Diseases, University of Texas Medical Branch, Galveston, TX.
J A PlanteWorld Reference Center for Emerging Viruses and Arboviruses, Institute for Human Infections and Immunity, and Department of Pathology and Center for Tropical Diseases, University of Texas Medical Branch, Galveston, TX.
P V AguilarWorld Reference Center for Emerging Viruses and Arboviruses, Institute for Human Infections and Immunity, and Department of Pathology and Center for Tropical Diseases, University of Texas Medical Branch, Galveston, TX.
D FernándezWorld Reference Center for Emerging Viruses and Arboviruses, Institute for Human Infections and Immunity, and Department of Pathology and Center for Tropical Diseases, University of Texas Medical Branch, Galveston, TX.
A NalcaU.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD.
A ToturaU.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD.
D DyerU.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD.
B KearneyU.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD.
M LackemeyerNational Institutes of Health, National Institute of Allergy and Infectious Diseases, Integrated Research Facility, Fort Detrick, MD.
J K BohannonNational Institutes of Health, National Institute of Allergy and Infectious Diseases, Integrated Research Facility, Fort Detrick, MD.
R JohnsonNational Institutes of Health, National Institute of Allergy and Infectious Diseases, Integrated Research Facility, Fort Detrick, MD.
R F GarryTulane School of Medicine, Tulane National Primate Research Center, New Orleans, LA.
D S Reed *Center for Vaccine Research, University of Pittsburgh, Pittsburgh, PA.
C J Roy *Tulane School of Medicine, Tulane National Primate Research Center, New Orleans, LA.

Funding

Tulane NPRC SPF Sheltered Outdoor Enclosure ExpansionP51OD011104 · OD · TULANE UNIVERSITY OF LOUISIANA · PI L Lee HAMM · 2012 to 2026
$142.4M
Technology CoreU19AI135995 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI Laura D. Hughes · 2018 to 2026
$32.0M
World Reference Center for Emerging Viruses and Arboviruses (WRCEVA)R24AI120942 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI WEAVER, SCOTT C · 2016 to 2024
$8.5M
Research Training Program on the Impact of Zoonotic and Vector-borne Viruses, Rickettsiae, and Leptospira in Acute Undifferentiated Febrile IllnessesD43TW010331 · FIC · UNIVERSITY OF TEXAS MED BR GALVESTON · PI AGUILAR, PATRICIA VERONICA, RODAS, JUAN DAVID · 2016 to 2025
$2.6M
NIAID NIH HHS HHSN272200700016INIAID NIH HHS HHSN272201800013CNIAID NIH HHS R24 AI120942NIAID NIH HHS U19 AI135995NIH HHS P51 OD011104
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID32511433
PMCPMC7217084

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.